Back to Results
First PageMeta Content
Clinical research / Pharmacology / Health / Entry inhibitors / Design of experiments / Maraviroc / Monogram Biosciences / Antiretroviral drug / CCR5 receptor antagonist / Medicine / Science / HIV/AIDS


Document Date: 2014-04-14 15:46:11

Open Document

File Size: 577,26 KB

Share Result on Facebook

City

Madrid / San Francisco / Belmont / Seattle / Mechelen / Bristol / New York / Washington / DC / New Orleans / Vancouver / Sandwich / Kent / Rosario / Basel / /

Company

Nature Publishing Group / Neural Networks / Roche Diagnostics / 2Pfizer Ltd / Armour / Princeton University Press / Creative Commons / Exprimo NV / Monogram Biosciences / Taylor & Francis Inc / Pfizer Ltd. / /

Continent

Europe / /

Country

Switzerland / Poland / Belgium / United States / Canada / United Kingdom / Spain / /

Currency

pence / /

/

Event

FDA Phase / /

IndustryTerm

HIV therapy / treatment of HIV / advance online publication / /

MedicalCondition

HIV / hepatitis C / HIV RNA / disease / viremia / AIDS / HIV/Aids / infection / anemia / chronic hepatitis C / /

MedicalTreatment

highly active antiretroviral therapy / /

Organization

Princeton University / /

Person

Caroline Shepherd / Nat / Richard Bellman / /

Position

driver / Walker / consultant / Author / forward / Marshall / /

Product

peginterferon / ribavirin / BLQ / HIV1 / /

ProvinceOrState

Louisiana / British Columbia / New York / Pennsylvania / California / /

Technology

anti-infectives / pharmacokinetics / pharmacodynamics / /

URL

http /

SocialTag